Adaphostin
Adaphostin (NSC-680410) is a small molecule inhibitor targeting the p210Bcr-Abl tyrosine kinase, exhibiting an IC50 of 14 μM. It has been utilized in research to study chronic myeloid leukemia (CML), demonstrating cytotoxic effects in vitro and showing antitumor activity in preclinical in vivo models.
Product Specifications
CAS Number
241127-58-2
Product Name Alternative
P210Bcr/abl, ROS, tyrosine kinase, 1-Adamantyl 4- ((2,5-Dihydroxybenzyl) Amino) Benzoate, Adaphostin, Apoptosis, Bcr-Abl, BcrAbl, chronic myelogenous leukemia, CML, Inhibitor, inhibit, myeloid, NSC 680410, NSC680410, NSC-680410
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Purity
97.31% (May vary between batches)
Solubility
DMSO:55 mg/mL (139.78 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.08 mM) ; Ethanol:< 40 mg/mL (101.66 mM)
Smiles
Oc1ccc (O) c (CNc2ccc (cc2) C (=O) OC23CC4CC (CC (C4) C2) C3) c1
Molecular Formula
C24H27NO4
Molecular Weight
393.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH030891 50 µg
Recombinant Human HAGH/GLO2/Glyoxalase II Protein (His Tag)
Sign In for Pricing
View Details GTR15099995 1 Vial
Lentiviral human CYB5R4 shRNA (UAS) - Lentiviral human CYB5R4 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details